Article
Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modeling.
Antiviral research - 1 Nov 2024
Lo Michael K, Jain Shilpi, Davies Katherine A, Sorvillo Teresa E, Welch Stephen R, Coleman-McCray JoAnn D, Chatterjee Payel, Hotard Anne L, O'Neal Troy, Flint Mike, Ai Huiwang, Albariño Cesar G, Spengler Jessica R, Montgomery Joel M, Spiropoulou Christina F
Abstract excerpt
Nipah virus (NiV) causes near-annual outbreaks of fatal encephalitis and respiratory disease in South Asia with a high mortality rate (∼70%). Since there are no approved therapeutics for NiV disease in humans, the WHO has designated NiV and henipaviral diseases priority pathogens for research and development. We generated a new recombinant green fluorescent reporter NiV of the circulating Bangladesh genotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
